Unknown

Dataset Information

0

Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial.


ABSTRACT: AIMS:Troponin levels are commonly elevated among patients hospitalized for heart failure (HF), but the prevalence and prognostic significance of early post-discharge troponin elevation are unclear. This study sought to describe the frequency and prognostic value of pre-discharge and post-discharge troponin elevation, including persistent troponin elevation from the inpatient to outpatient settings. METHODS AND RESULTS:The ASTRONAUT trial (NCT00894387; http://www.clinicaltrials.gov) enrolled hospitalized HF patients with ejection fraction ?40% and measured troponin I prior to discharge (i.e. study baseline) and at 1-month follow-up in a core laboratory (elevation defined as >0.04?ng/mL). This analysis included 1469 (91.0%) patients with pre-discharge troponin data. Overall, 41.5% and 29.9% of patients had elevated pre-discharge [median: 0.09?ng/mL; interquartile range (IQR): 0.06-0.19?ng/mL] and 1-month (median: 0.09?ng/mL; IQR: 0.06-0.15?ng/mL) troponin levels, respectively. Among patients with pre-discharge troponin elevation, 60.4% had persistent elevation at 1?month. After adjustment, pre-discharge troponin elevation was not associated with 12-month clinical outcomes. In contrast, 1-month troponin elevation was independently predictive of increased all-cause mortality [hazard ratio (HR) 1.59, 95% confidence interval (CI) 1.18-2.13] and cardiovascular mortality or HF hospitalization (HR 1.28, 95% CI 1.03-1.58) at 12?months. Associations between 1-month troponin elevation and outcomes were similar among patients with newly elevated (i.e. normal pre-discharge) and persistently elevated levels (interaction P???0.16). The prognostic value of 1-month troponin elevation for 12-month mortality was driven by a pronounced association among patients with coronary artery disease (interaction P?=?0.009). CONCLUSIONS:In this hospitalized HF population, troponin I elevation was common during index hospitalization and at 1-month follow-up. Elevated troponin I level at 1?month, but not pre-discharge, was independently predictive of increased clinical events at 12?months. Early post-discharge troponin I measurement may offer a practical means of risk stratification and should be investigated as a therapeutic target.

SUBMITTER: Greene SJ 

PROVIDER: S-EPMC6429915 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial.

Greene Stephen J SJ   Butler Javed J   Fonarow Gregg C GC   Subacius Haris P HP   Ambrosy Andrew P AP   Vaduganathan Muthiah M   Triggiani Marco M   Solomon Scott D SD   Lewis Eldrin F EF   Maggioni Aldo P AP   Böhm Michael M   Chioncel Ovidiu O   Nodari Savina S   Senni Michele M   Zannad Faiez F   Gheorghiade Mihai M  

European journal of heart failure 20171017 2


<h4>Aims</h4>Troponin levels are commonly elevated among patients hospitalized for heart failure (HF), but the prevalence and prognostic significance of early post-discharge troponin elevation are unclear. This study sought to describe the frequency and prognostic value of pre-discharge and post-discharge troponin elevation, including persistent troponin elevation from the inpatient to outpatient settings.<h4>Methods and results</h4>The ASTRONAUT trial (NCT00894387; http://www.clinicaltrials.gov  ...[more]

Similar Datasets

| S-EPMC4151504 | biostudies-literature
| S-EPMC10356099 | biostudies-literature
| S-EPMC8120390 | biostudies-literature
| S-EPMC8475054 | biostudies-literature
| S-EPMC10053299 | biostudies-literature
| S-EPMC6467695 | biostudies-literature
| S-EPMC7675099 | biostudies-literature
| S-EPMC8318456 | biostudies-literature
| S-EPMC9065872 | biostudies-literature
| S-EPMC9303456 | biostudies-literature